| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/13/2003 | US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases. |
| 02/13/2003 | US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 02/13/2003 | CA2468925A1 Platelet adp receptor inhibitors |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455772A1 Substituted isoindoles and their use |
| 02/13/2003 | CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1283448A2 Electrophotographic organophotoreceptors with charge transport compounds |
| 02/12/2003 | EP1283210A1 Process for preparation of sulfonamide derivatives and crystals thereof |
| 02/12/2003 | EP1283209A1 Novel benzothiophene derivatives |
| 02/12/2003 | EP1283208A1 Novel benzofuran derivatives |
| 02/12/2003 | EP1283055A1 Soluble beta amyloid precursor protein secretion promoters |
| 02/12/2003 | EP1282617A1 Hydantoin derivatives with affinity for somatostatin receptors |
| 02/12/2003 | EP1282616A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282609A2 Piperazinedione compounds |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282418A2 Use of pyrazole derivatives for treating infertility |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | EP0926146B1 Chromene compounds |
| 02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/12/2003 | CN1396807A 除草组合物 Herbicidal compositions |
| 02/12/2003 | CN1396163A Thiophen sulfuryl compound |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/12/2003 | CN1101380C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518301 Better selectivity than estrogen for the estrogen receptor-beta over receptor-alpha; treatment of Alzheimer's disease, anxiety, depression, osteoporosis, cardiovascular disease, rheumatoid arthritis, or prostate cancer |
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518266 1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | CA2047237C Chroman derivatives |
| 02/11/2003 | CA2041135C Method for the photochemical isomerisation of organic compounds under the influence of a photosensitizer |
| 02/06/2003 | WO2003010361A2 Nitrogen atom transfer |
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010163A1 Novel compounds |
| 02/06/2003 | WO2003010160A2 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2003009845A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 02/06/2003 | WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002010137A9 Indazole derivatives as jnk inhibitors |
| 02/06/2003 | US20030028034 Nematicidal pyrazoles |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer |
| 02/06/2003 | US20030027855 Preparation of a derivative or analog of baccatin III or 10-desacetyl baccatin III having a C9 hydroxy substituent by selective reduction of the C9 keto compound |
| 02/06/2003 | US20030027842 Halogenobenzimidazoles |
| 02/06/2003 | US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters |
| 02/06/2003 | US20030027829 Potassium channel inhibitors |
| 02/06/2003 | US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 02/06/2003 | US20030027810 Nicotine receptor ligands |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2454702A1 Novel compounds |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452259A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/05/2003 | EP1280800A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280773A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | CN1395575A Novel piperidine compounds and drugs containing the same |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395567A New imidazole derivatives |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1394859A Intermediate for preparing cyclopentane formamide compound and its preparation method |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100771C Phosphononooxymethyl ethers for taxame derivatives |
| 02/05/2003 | CN1100762C Substituted pyrazolyl-pyrazole derivatives and their use as herbicides |
| 02/05/2003 | CN1100761C Benzyloxy substituted aryl copounds and their use as fungicides and insecticides |
| 02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515151 Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515013 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |